Search details
1.
Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor.
Mol Pharm
; 20(2): 1394-1403, 2023 02 06.
Article
in English
| MEDLINE | ID: mdl-36668683
2.
Fibroblast Activation Protein Targeting Probe with Gly-Pro Sequence for PET of Glioblastoma.
Mol Pharm
; 20(8): 4120-4128, 2023 08 07.
Article
in English
| MEDLINE | ID: mdl-37487027
3.
PSC subtyping based on TTF-1 and p40 expression reveals distinct molecular characteristics and therapeutic strategies.
Int J Cancer
; 151(5): 717-729, 2022 09 01.
Article
in English
| MEDLINE | ID: mdl-35612583
4.
Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.
Toxicol Appl Pharmacol
; 365: 71-83, 2019 02 15.
Article
in English
| MEDLINE | ID: mdl-30633885
5.
Correction to "Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor".
Mol Pharm
; 20(8): 4335, 2023 Aug 07.
Article
in English
| MEDLINE | ID: mdl-37494551
6.
Pathological response and tumor stroma immunogenic features predict long-term survival in non-small cell lung cancer after neoadjuvant chemotherapy.
Cell Oncol (Dordr)
; 2024 Feb 06.
Article
in English
| MEDLINE | ID: mdl-38319500
7.
Treatment patterns and clinical outcomes of patients with resectable non-small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World).
J Thorac Cardiovasc Surg
; 2024 Feb 10.
Article
in English
| MEDLINE | ID: mdl-38342430
8.
Development of a Novel HER2-Targeted Peptide Probe for Dual-Modal Imaging of Tumors.
J Med Chem
; 66(11): 7523-7533, 2023 06 08.
Article
in English
| MEDLINE | ID: mdl-37246901
9.
Development and validation of a nomogram based on preoperative variables for predicting recurrence-free survival in stage IA lung adenocarcinoma.
Thorac Cancer
; 14(31): 3108-3118, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37793977
10.
A strategy to reduce the false-positive rate after low-dose computed tomography in lung cancer screening: A multicenter prospective cohort study.
Cancer Med
; 12(13): 14781-14793, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37199391
11.
Multimodality Treatment of Pulmonary Sarcomatoid Carcinoma: A Review of Current State of Art.
J Oncol
; 2022: 8541157, 2022.
Article
in English
| MEDLINE | ID: mdl-35368903
12.
The Deubiquitinase USP13 Maintains Cancer Cell Stemness by Promoting FASN Stability in Small Cell Lung Cancer.
Front Oncol
; 12: 899987, 2022.
Article
in English
| MEDLINE | ID: mdl-35898882
13.
A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability.
Cancer Commun (Lond)
; 42(10): 1008-1027, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-35975322
14.
Whole-genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancer.
Clin Transl Med
; 12(8): e1014, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35998020
15.
External validation of the eighth edition of the TNM classification for lung cancer in small cell lung cancer.
Lung Cancer
; 170: 98-104, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35749952
16.
Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Front Immunol
; 12: 669750, 2021.
Article
in English
| MEDLINE | ID: mdl-34054840
17.
Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication.
Front Cell Dev Biol
; 9: 743724, 2021.
Article
in English
| MEDLINE | ID: mdl-34746138
18.
PD-L1 and CD47 co-expression predicts survival and enlightens future dual-targeting immunotherapy in non-small cell lung cancer.
Thorac Cancer
; 12(11): 1743-1751, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33979899
19.
Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers.
Front Mol Biosci
; 8: 587436, 2021.
Article
in English
| MEDLINE | ID: mdl-33778001
20.
Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes.
Nat Commun
; 12(1): 3785, 2021 06 18.
Article
in English
| MEDLINE | ID: mdl-34145257